



| Name Dr. Candace Berardinelli, PhD |
|
| Title Dean, School of Nursing |
|
| Phone 303-458-4232 800-388-2366 x4232 Fax: 303-964-5325 |
|
| Location 327 Carroll Hall |
|
| e-mail cberardi@regis.edu |
|
|
|
|
|
|
|
Berardinelli, C. & Kupecz, D. (2002). Lower the pressure with a new antihypertensive. Nurse Practitioner, 27(8), 42-44. Berardinelli, C. & Kupecz, D. (2002). Ease symptoms of pulmonary hypertension with bosentan. Nurse Practitioner, 27 (6), 51-3. Berardinelli, C. & Kupecz, D. (2002). Drug and device approval highlights from 2001. Nurse Practitioner, 27(2), 21-3. Berardinelli, C. (2001).National Council of State Boards of Nursing responds to safety issues. Colorado Nurse. 100(4), 24. Berardinelli, C. & Kupecz, D. (2001). Keeping up with recent ophthalmic drug approvals. Nurse Practitioner, 26(4), 61-2,64, 67. Berardinelli, C. & Kupecz, D. (2001). Drug treatments and topics: The year in review. Nurse Practitioner., 26(2), 18, 21-2, 25-6. Berardinelli, C. & Kupecz, D. (2000). Linezolid: A new class of antibiotic. Nurse Practitioner, 25(11), 62-4. Berardinelli, C. & Kupecz, D. (2000) Insulin glargine: A novel basal insulin analog. Nurse Practitioner, 25 (9), 68, 74-5, 78. | |
|
|
|
|
|
|